HuagongsheHuagongshe Chemistry Print Report · For research reference only
Adenine → 9-((2-(2-Chlorophenyl)-8-methylquinolin-3-yl)methyl)-9H-purin-6-amine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Adenine | HCID 190 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 3-(Bromomethyl)-2-(2-chlorophenyl)-8-methylquinoline | HCID 57556169 | — |
| Reactant | 3-(Bromomethyl)-8-methyl-2-(2-methylphenyl)quinoline | HCID 57708065 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 9-((2-(2-Chlorophenyl)-8-methylquinolin-3-yl)methyl)-9H-purin-6-amine | HCID 25095510 | — |
Reaction Steps
A mixture of 3-(bromomethyl)-2-(2-chlorophenyl)-8-methylquinoline (66 mg, 0.19 mmol), {prepared in a similar way as 3-(bromomethyl)-8-methyl-2-o-tolylquinoline, example 9} adenine (39 mg, 0.29 mmol), and cesium carbonate (124 mg, 0.38 mmol) in DMF (0.7 mL) was stirred at rt for 2 h. The crude mixture was evaporated onto silica gel and purified by flash chromatography (Biotage Si 25+M) eluting with MeOH/CH2Cl2 (5% to 10%). The resulting white solid was further purified by HPLC (Berger SFC) eluting with i-PrOH/CO2/DEA to provide a white solid [PI3Kδ IC50=2130 nM]. MS (ESI+) m/z=401.1 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07919498B2 |
| Source dataset | uspto-grants-2011_04 |
| ORD ID | ord-fe931b7ed25c438c8b88ffb427c02b16 |
| Source note | uspto-grants-2011_04 |